- call +1-201-465-4211
- email sales@mrinsights.biz
Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
Scope of the Report:
This report focuses on the Molecular Imaging Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
North America is the leading region of molecular imaging agents market owing to increasing awareness for molecular imaging in disease diagnosis and monitoring. Europe and Asia region are also growing at rapid pace for molecular imaging agents owing to increase in research and development (clinical trials) activities across biopharmaceutical drugs.
The worldwide market for Molecular Imaging Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
General Electric
Bracco Diagnostic
Eisai
Guerbet
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Market Segment by Applications, can be divided into
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
There are 15 Chapters to deeply display the global Molecular Imaging Agents market.
Chapter 1, to describe Molecular Imaging Agents Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Molecular Imaging Agents, with sales, revenue, and price of Molecular Imaging Agents, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Molecular Imaging Agents, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Molecular Imaging Agents market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Molecular Imaging Agents sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Molecular Imaging Agents Introduction
1.2 Market Analysis by Type
1.2.1 Small Molecules
1.2.2 Peptides
1.2.3 Engineered Protein Fragments
1.2.4 Aptamers
1.2.5 Nanoparticles
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Gastrointestinal Disorders
1.3.4 Neurology Disorders
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 General Electric
2.1.1 Business Overview
2.1.2 Molecular Imaging Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 General Electric Molecular Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bracco Diagnostic
2.2.1 Business Overview
2.2.2 Molecular Imaging Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bracco Diagnostic Molecular Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eisai
2.3.1 Business Overview
2.3.2 Molecular Imaging Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eisai Molecular Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Guerbet
2.4.1 Business Overview
2.4.2 Molecular Imaging Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Guerbet Molecular Imaging Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Molecular Imaging Agents Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Molecular Imaging Agents Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Molecular Imaging Agents Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Molecular Imaging Agents Manufacturer Market Share in 2017
3.3.2 Top 6 Molecular Imaging Agents Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Molecular Imaging Agents Market Analysis by Regions
4.1 Global Molecular Imaging Agents Sales, Revenue and Market Share by Regions
4.1.1 Global Molecular Imaging Agents Sales and Market Share by Regions (2013-2018)
4.1.2 Global Molecular Imaging Agents Revenue and Market Share by Regions (2013-2018)
4.2 North America Molecular Imaging Agents Sales and Growth Rate (2013-2018)
4.3 Europe Molecular Imaging Agents Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Molecular Imaging Agents Sales and Growth Rate (2013-2018)
4.5 South America Molecular Imaging Agents Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Molecular Imaging Agents Sales and Growth Rate (2013-2018)
5 North America Molecular Imaging Agents by Countries
5.1 North America Molecular Imaging Agents Sales, Revenue and Market Share by Countries
5.1.1 North America Molecular Imaging Agents Sales and Market Share by Countries (2013-2018)
5.1.2 North America Molecular Imaging Agents Revenue and Market Share by Countries (2013-2018)
5.2 United States Molecular Imaging Agents Sales and Growth Rate (2013-2018)
5.3 Canada Molecular Imaging Agents Sales and Growth Rate (2013-2018)
5.4 Mexico Molecular Imaging Agents Sales and Growth Rate (2013-2018)
6 Europe Molecular Imaging Agents by Countries
6.1 Europe Molecular Imaging Agents Sales, Revenue and Market Share by Countries
6.1.1 Europe Molecular Imaging Agents Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Molecular Imaging Agents Revenue and Market Share by Countries (2013-2018)
6.2 Germany Molecular Imaging Agents Sales and Growth Rate (2013-2018)
6.3 UK Molecular Imaging Agents Sales and Growth Rate (2013-2018)
6.4 France Molecular Imaging Agents Sales and Growth Rate (2013-2018)
6.5 Russia Molecular Imaging Agents Sales and Growth Rate (2013-2018)
6.6 Italy Molecular Imaging Agents Sales and Growth Rate (2013-2018)
7 Asia-Pacific Molecular Imaging Agents by Countries
7.1 Asia-Pacific Molecular Imaging Agents Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Molecular Imaging Agents Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Molecular Imaging Agents Revenue and Market Share by Countries (2013-2018)
7.2 China Molecular Imaging Agents Sales and Growth Rate (2013-2018)
7.3 Japan Molecular Imaging Agents Sales and Growth Rate (2013-2018)
7.4 Korea Molecular Imaging Agents Sales and Growth Rate (2013-2018)
7.5 India Molecular Imaging Agents Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Molecular Imaging Agents Sales and Growth Rate (2013-2018)
8 South America Molecular Imaging Agents by Countries
8.1 South America Molecular Imaging Agents Sales, Revenue and Market Share by Countries
8.1.1 South America Molecular Imaging Agents Sales and Market Share by Countries (2013-2018)
8.1.2 South America Molecular Imaging Agents Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Molecular Imaging Agents Sales and Growth Rate (2013-2018)
8.3 Argentina Molecular Imaging Agents Sales and Growth Rate (2013-2018)
8.4 Colombia Molecular Imaging Agents Sales and Growth Rate (2013-2018)
9 Middle East and Africa Molecular Imaging Agents by Countries
9.1 Middle East and Africa Molecular Imaging Agents Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Molecular Imaging Agents Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Molecular Imaging Agents Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Molecular Imaging Agents Sales and Growth Rate (2013-2018)
9.3 UAE Molecular Imaging Agents Sales and Growth Rate (2013-2018)
9.4 Egypt Molecular Imaging Agents Sales and Growth Rate (2013-2018)
9.5 Nigeria Molecular Imaging Agents Sales and Growth Rate (2013-2018)
9.6 South Africa Molecular Imaging Agents Sales and Growth Rate (2013-2018)
10 Global Molecular Imaging Agents Market Segment by Type
10.1 Global Molecular Imaging Agents Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Molecular Imaging Agents Sales and Market Share by Type (2013-2018)
10.1.2 Global Molecular Imaging Agents Revenue and Market Share by Type (2013-2018)
10.2 Small Molecules Sales Growth and Price
10.2.1 Global Small Molecules Sales Growth (2013-2018)
10.2.2 Global Small Molecules Price (2013-2018)
10.3 Peptides Sales Growth and Price
10.3.1 Global Peptides Sales Growth (2013-2018)
10.3.2 Global Peptides Price (2013-2018)
10.4 Engineered Protein Fragments Sales Growth and Price
10.4.1 Global Engineered Protein Fragments Sales Growth (2013-2018)
10.4.2 Global Engineered Protein Fragments Price (2013-2018)
10.5 Aptamers Sales Growth and Price
10.5.1 Global Aptamers Sales Growth (2013-2018)
10.5.2 Global Aptamers Price (2013-2018)
10.6 Nanoparticles Sales Growth and Price
10.6.1 Global Nanoparticles Sales Growth (2013-2018)
10.6.2 Global Nanoparticles Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Molecular Imaging Agents Market Segment by Application
11.1 Global Molecular Imaging Agents Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Cardiology Sales Growth (2013-2018)
11.4 Gastrointestinal Disorders Sales Growth (2013-2018)
11.5 Neurology Disorders Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Molecular Imaging Agents Market Forecast (2018-2023)
12.1 Global Molecular Imaging Agents Sales, Revenue and Growth Rate (2018-2023)
12.2 Molecular Imaging Agents Market Forecast by Regions (2018-2023)
12.2.1 North America Molecular Imaging Agents Market Forecast (2018-2023)
12.2.2 Europe Molecular Imaging Agents Market Forecast (2018-2023)
12.2.3 Asia-Pacific Molecular Imaging Agents Market Forecast (2018-2023)
12.2.4 South America Molecular Imaging Agents Market Forecast (2018-2023)
12.2.5 Middle East and Africa Molecular Imaging Agents Market Forecast (2018-2023)
12.3 Molecular Imaging Agents Market Forecast by Type (2018-2023)
12.3.1 Global Molecular Imaging Agents Sales Forecast by Type (2018-2023)
12.3.2 Global Molecular Imaging Agents Market Share Forecast by Type (2018-2023)
12.4 Molecular Imaging Agents Market Forecast by Application (2018-2023)
12.4.1 Global Molecular Imaging Agents Sales Forecast by Application (2018-2023)
12.4.2 Global Molecular Imaging Agents Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Molecular Imaging Agents Picture
Table Product Specifications of Molecular Imaging Agents
Figure Global Sales Market Share of Molecular Imaging Agents by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
